Disclosure Of Cash Flow Statement [Text Block]

Sopharma AD - Filing #6218824

Concept As at
2021-12-31
As at
2021-01-01
As at
2020-12-31
As at
2020-01-01
Disclosure of cash flow statement [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
37,722,000 BGN
25,293,000 BGN
Cash and cash equivalents if different from statement of financial position
37,717,000 BGN
25,139,000 BGN
25,139,000 BGN
27,362,000 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.